Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck To Pay $688 Million To Shareholders For Delaying Vytorin Results
Merck To Pay $688 Million To Shareholders For Delaying Vytorin Results
Merck To Pay $688 Million To Shareholders For Delaying Vytorin Results
Submitted by
admin
on February 14, 2013 - 9:57am
Source:
Forbes
News Tags:
Vytorin
Merck
settlements
ENHANCE
Headline:
Merck To Pay $688 Million To Shareholders For Delaying Vytorin Results
Do Not Allow Advertisers to Use My Personal information
